Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


25.09.2017

1 Acta Haematol
1 Am J Clin Pathol
1 Am J Hematol
4 Blood
7 Br J Haematol
1 Cancer Res
1 Exp Hematol
1 Int J Hematol
6 Leuk Lymphoma
3 Leuk Res
7 Leukemia
2 Oncogene
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Semin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  2. YOU E, Cho YU, Jang S, Seo EJ, et al
    Frequency and Clinicopathologic Features of RUNX1 Mutations in Patients With Acute Myeloid Leukemia Not Otherwise Specified.
    Am J Clin Pathol. 2017;148:64-72.
    PubMed     Text format     Abstract available


    Am J Hematol

  3. CHANG YJ, Zhao XS, Wang Y, Liu YR, et al
    Effects of Pre- and Post-transplantation Minimal Residual Disease on Outcomes in Pediatric Patients with Acute Myeloid Leukemia Receiving Human Leukocyte Antigen-matched or Mismatched Related Donor Allografts.
    Am J Hematol. 2017 Sep 20. doi: 10.1002/ajh.24910.
    PubMed     Text format    


    Blood

  4. CHAUDHRY P, Singh M, Triche TJ, Guzman M, et al
    GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML.
    Blood. 2017;129:3465-3475.
    PubMed     Text format     Abstract available

  5. LEVIS M
    Midostaurin approved for FLT3-mutated AML.
    Blood. 2017;129:3403-3406.
    PubMed     Text format     Abstract available

  6. WANG HY, Feldman AL
    Exuberant nodal proliferation of mature plasmacytoid dendritic cells in a patient with chronic myelomonocytic leukemia.
    Blood. 2017;130:1387.
    PubMed     Text format    

  7. ZURLI V, Wimmer G, Cattaneo F, Candi V, et al
    Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
    Blood. 2017 Sep 20. pii: blood-2017-03-775858. doi: 10.1182/blood-2017-03-775858
    PubMed     Text format     Abstract available


    Br J Haematol

  8. EYRE TA, Schuh A
    An update for Richter syndrome - new directions and developments.
    Br J Haematol. 2017;178:508-520.
    PubMed     Text format     Abstract available

  9. MESSINA M, Chiaretti S, Fedullo AL, Piciocchi A, et al
    Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
    Br J Haematol. 2017;178:583-587.
    PubMed     Text format     Abstract available

  10. KARLSSON L, Forestier E, Hasle H, Jahnukainen K, et al
    Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.
    Br J Haematol. 2017;178:592-602.
    PubMed     Text format     Abstract available

  11. EPPERLA N, Pham AQ, Burnette BL, Wiseman GA, et al
    Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
    Br J Haematol. 2017 May 3. doi: 10.1111/bjh.14688.
    PubMed     Text format     Abstract available

  12. ZELLER B, Glosli H, Forestier E, Ha SY, et al
    Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 x 109 /l. The NOPHO experience 1984-2014.
    Br J Haematol. 2017;178:448-456.
    PubMed     Text format     Abstract available

  13. STRATI P, Parikh SA, Chaffee KG, Kay NE, et al
    Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.
    Br J Haematol. 2017;178:394-402.
    PubMed     Text format     Abstract available

  14. SCHETELIG J, de Wreede LC, Andersen NS, Moreno C, et al
    Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT).
    Br J Haematol. 2017;178:521-533.
    PubMed     Text format     Abstract available


    Cancer Res

  15. JING W, Gershan JA, Holzhauer S, Weber J, et al
    T cells deficient in diacylglycerol kinase-zeta are resistant to PD-1 inhibition and help create persistent host immunity to leukemia.
    Cancer Res. 2017 Sep 15. pii: canres.1309.2017.
    PubMed     Text format     Abstract available


    Exp Hematol

  16. LAGACE K, Barabe F, Hebert J, Cellot S, et al
    Identification of novel biomarkers for MLL translocated acute myeloid leukemia.
    Exp Hematol. 2017 Sep 11. pii: S0301-472X(17)30758.
    PubMed     Text format     Abstract available


    Int J Hematol

  17. TAKAHASHI N, Tauchi T, Kitamura K, Miyamura K, et al
    Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
    Int J Hematol. 2017 Sep 19. doi: 10.1007/s12185-017-2334.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  18. MULANOVICH V, Kontoyiannis DP
    Acute myeloid leukemia and the infectious diseases consultant.
    Leuk Lymphoma. 2017 Sep 15:1-8. doi: 10.1080/10428194.2017.1365861.
    PubMed     Text format     Abstract available

  19. VLIJM-KIEVIT A, Jorna NGE, Moll E, Pajkrt E, et al
    Acute lymphoblastic leukemia during the third trimester of pregnancy.
    Leuk Lymphoma. 2017 Sep 15:1-3. doi: 10.1080/10428194.2017.1375104.
    PubMed     Text format    

  20. RIZZOTTO L, Lai TH, Bottoni A, Woyach JA, et al
    Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.
    Leuk Lymphoma. 2017 Sep 18:1-5. doi: 10.1080/10428194.2017.1376742.
    PubMed     Text format    

  21. KREINITZ N, Polliack A, Tadmor T
    Chronic lymphocytic leukemia is becoming more complex: how to define complex karyotype?
    Leuk Lymphoma. 2017 Sep 18:1-2. doi: 10.1080/10428194.2017.1376748.
    PubMed     Text format    

  22. ANDRITSOS LA, Grieselhuber NR, Anghelina M, Rogers KA, et al
    Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.
    Leuk Lymphoma. 2017 Sep 18:1-4. doi: 10.1080/10428194.2017.1365853.
    PubMed     Text format    

  23. APPLEBY N, O'Brien D, Quinn FM, Smyth L, et al
    Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-
    Leuk Lymphoma. 2017 Sep 19:1-10. doi: 10.1080/10428194.2017.1376746.
    PubMed     Text format     Abstract available


    Leuk Res

  24. TAMAI M, Furuichi Y, Kasai S, Ando N, et al
    TGFbeta1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
    Leuk Res. 2017;61:68-76.
    PubMed     Text format     Abstract available

  25. DARJI A, Desai N, Modi R, Khamar B, et al
    Establishment of cell line with NK/NKT phenotype from myeloid NK cell acute leukemia.
    Leuk Res. 2017;61:77-83.
    PubMed     Text format     Abstract available

  26. WANG F, Jia JS, Wang J, Zhao T, et al
    The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia.
    Leuk Res. 2017;61:84-88.
    PubMed     Text format     Abstract available


    Leukemia

  27. MCCRACKEN AN, McMonigle RJ, Tessier J, Fransson R, et al
    Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation.
    Leukemia. 2017;31:669-677.
    PubMed     Text format     Abstract available

  28. WAIBEL M, Vervoort SJ, Kong IY, Heinzel S, et al
    Epigenetic targeting of Notch1 driven transcription using the HDACi panobinostat is a potential therapy against T cell acute lymphoblastic leukemia.
    Leukemia. 2017 Sep 15. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  29. SAKURA T, Hayakawa F, Sugiura I, Murayama T, et al
    High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG.
    Leukemia. 2017 Sep 15. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  30. HOSPITAL MA, Jacquel A, Mazed F, Saland E, et al
    RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.
    Leukemia. 2017 Sep 15. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  31. JO S, Lee JH, Mattei JJ, Barrett DM, et al
    Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.
    Leukemia. 2017 Sep 19. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  32. NADEU F, Clot G, Delgado J, Martin-Garcia D, et al
    Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
    Leukemia. 2017 Sep 19. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  33. DEL GIUDICE I, Rigolin GM, Raponi S, Cafforio L, et al
    Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low and very-low risk genetic profile.
    Leukemia. 2017 Sep 19. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncogene

  34. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Text format     Abstract available

  35. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Text format     Abstract available


    PLoS One

  36. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
    Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
    PLoS One. 2017;12:e0179974.
    PubMed     Text format     Abstract available

  37. BELVISO S, Iuliano R, Amato R, Perrotti N, et al
    The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells.
    PLoS One. 2017;12:e0178174.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  38. RASSENTI LZ, Balatti V, Ghia EM, Palamarchuk A, et al
    MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708264.
    PubMed     Text format     Abstract available


    Semin Oncol

  39. BARWE SP, Quagliano A, Gopalakrishnapillai A
    Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.
    Semin Oncol. 2017;44:101-112.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: